Eko Low Ejection Fraction Tool (ELEFT) vs Study Watch with Irregular Pulse Monitor (Home)
AI Verdict
Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if you need a rapid, non-invasive screening tool to aid in the early detection of low ejection fraction during routine physical examinations. This tool is ideal for clinicians seeking to quickly assess heart failure risk at the point of care using their Eko digital stethoscope.
View Eko Low Ejection Fraction Tool (ELEFT) →Choose Study Watch with Irregular Pulse Monitor (Home) if…
Choose Verily Study Watch with Irregular Pulse Monitor (Home) if you require a prescription-only wearable for continuous, long-term remote physiological data collection in clinical research or for monitoring patients for irregular heart rhythms like AFib. This device is best suited for unobtrusive, extended data capture and advanced cloud-based analytics beyond a single point-of-care assessment.
View Study Watch with Irregular Pulse Monitor (Home) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Low Ejection Fraction Tool (ELEFT) | Study Watch with Irregular Pulse Monitor (Home) |
|---|---|---|
| FDA Status | Cleared AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Low Ejection Fraction Tool (ELEFT)Eko Low Ejection Fraction Tool (ELEFT) integrates seamlessly into routine physical exams, providing results in approximately 15 seconds using a familiar stethoscope. This makes it highly usable within existing clinical workflows. The Verily Study Watch, while unobtrusive, is a wearable device that requires patient adherence and potentially more management for the patient and clinician for ongoing monitoring.
Clinical Value
Eko Low Ejection Fraction Tool (ELEFT)Both tools are FDA-cleared and address significant cardiac conditions. ELEFT offers early detection of low ejection fraction, a key indicator of heart failure, directly during a routine physical exam, which is crucial for proactive screening. The Verily Study Watch focuses on irregular pulse monitoring for AFib and broader physiological data collection for research and ongoing monitoring, which is valuable but less focused on immediate screening for a critical condition in a primary care setting.
Pricing & Value
TieBoth tools require direct contact for pricing, and neither provides publicly available pricing details. Without specific cost information or a clear understanding of the full scope of their respective enterprise offerings, it is not possible to definitively determine which provides better value.
Enterprise Readiness
Eko Low Ejection Fraction Tool (ELEFT)ELEFT is explicitly positioned as part of Eko's SENSORAu2122 platform, an enterprise solution, and clearly states it is HIPAA compliant with a Business Associate Agreement (BAA). While Verily also offers a BAA and states its services may be subject to HIPAA, a reported lawsuit alleging past HIPAA breaches raises a potential concern regarding its historical enterprise readiness, even if current compliance is asserted.
Innovation
TieELEFT demonstrates innovation by integrating AI-powered low ejection fraction detection into a standard stethoscope, offering rapid diagnostic insights during a routine physical. The Verily Study Watch is innovative through its comprehensive suite of physiological and environmental sensors, long battery life, and secure, continuous data collection in a wearable form factor, enabling extensive monitoring and research capabilities. Both represent significant advancements in their respective applications.
Support & Docs
Eko Low Ejection Fraction Tool (ELEFT)Eko Health provides a comprehensive online Help Center with user manuals, FAQs, troubleshooting guides, and direct contact options for customer support, catering to both individual and enterprise customers. Verily Study Watch documentation is primarily geared towards clinical research and technical specifications, with less readily available direct user support resources for clinicians or patients in a general healthcare setting.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Low Ejection Fraction Tool (ELEFT) | Study Watch with Irregular Pulse Monitor (Home) |
|---|---|---|
| Tool Name | Eko Low Ejection Fraction Tool (ELEFT) | Study Watch with Irregular Pulse Monitor (Home) |
| Company | Eko Health | Verily Life Sciences LLC |
| Primary Detection/Monitoring | AI-powered low ejection fraction detection, aids in early identification of heart failure risk. | On-demand single-channel ECG measurement, irregular pulse monitoring for atrial fibrillation (AFib) detection. |
| Device Type | AI algorithm integrated with digital stethoscopes. | Wearable device (Study Watch). |
| Prescription Requirement | Not specified | Prescription-only |
| Key Data Analyzed/Sensors | Analyzes ECG and heart sound recordings. | On-demand single-channel ECG, irregular pulse monitoring, multiple physiological sensors (heart rate, electrodermal activity, inertial movements), environmental sensors. |
Videos
Demos, reviews, and walkthroughs featuring Eko Low Ejection Fraction Tool (ELEFT) and Study Watch with Irregular Pulse Monitor (Home).
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Low Ejection Fraction Tool (ELEFT) or Study Watch with Irregular Pulse Monitor (Home)
- Study Watch with Irregular Pulse Monitor (Home) vs Cardiomo
- Study Watch with Irregular Pulse Monitor (Home) vs PMcardio
- Study Watch with Irregular Pulse Monitor (Home) vs Sleepiz One+
- Study Watch with Irregular Pulse Monitor (Home) vs EchoNext
- Eko Low Ejection Fraction Tool (ELEFT) vs EchoNext
- Eko Low Ejection Fraction Tool (ELEFT) vs PMcardio
Backers
Who funded each tool's parent company.